To date, a large number of long non-coding RNAs (lncRNAs) have been recently discovered through functional genomics studies. Importantly, lncRNAs have been shown, in many cases, to function as master regulators for gene expression and thus, they can play a critical role in various biological functions and disease processes including cancer. Although the lncRNA-mediated gene expression involves various mechanisms, such as regulation of transcription, translation, protein modification, and the formation of RNA-protein or protein-protein complexes, in this review, we discuss the latest developments primarily in important cell signaling pathways regulated by lncRNAs in cancer.

LncRNA-mediated regulation of cell signaling in cancer.

Toll-like Receptors and the Control of Immunity.

TNF is a pleiotropic cytokine with important functions in homeostasis and disease pathogenesis. Recent discoveries have provided insights into TNF biology that introduce new concepts for the development of therapeutics for TNF-mediated diseases. The model of TNF receptor signalling has been extended to include linear ubiquitination and the formation of distinct signalling complexes that are linked with different functional outcomes, such as inflammation, apoptosis and necroptosis. Our understanding of TNF-induced gene expression has been enriched by the discovery of epigenetic mechanisms and concepts related to cellular priming, tolerization and induction of 'short-term transcriptional memory'. Identification of distinct homeostatic or pathogenic TNF-induced signalling pathways has introduced the concept of selectively inhibiting the deleterious effects of TNF while preserving its homeostatic bioactivities for therapeutic purposes. In this Review, we present molecular mechanisms underlying the roles of TNF in homeostasis and inflammatory disease pathogenesis, and discuss novel strategies to advance therapeutic paradigms for the treatment of TNF-mediated diseases.

/pdf/tnf-biology-pathogenic-mechanisms-and-emerging-therapeutic-2uzdvwlov2.pdf

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

A major shift in our understanding of genome regulation has emerged recently. It is now apparent that the majority of cellular transcripts do not code for proteins, and many of them are long noncoding RNAs (lncRNAs). Increasingly, studies suggest that lncRNAs regulate gene expression through diverse mechanisms. We review emerging mechanistic views of lncRNAs in gene regulation in the cell nucleus. We discuss the functional interactions that lncRNAs establish with other molecules as well as the relationship between lncRNA transcription and function. While some of these mechanisms are specific to lncRNAs, others might be shared with other types of genes.

/pdf/the-multidimensional-mechanisms-of-long-noncoding-rna-lxfgic7602.pdf

The multidimensional mechanisms of long noncoding RNA function

Since decades it has been known that non-protein-coding RNAs have important cellular functions. Deep sequencing recently facilitated the discovery of thousands of novel transcripts, now classified as long noncoding RNAs (lncRNAs), in many vertebrate and invertebrate species. LncRNAs are involved in a wide range of cellular mechanisms, from almost all aspects of gene expression to protein translation and stability. Recent findings implicate lncRNAs as key players of cellular differentiation, cell lineage choice, organogenesis and tissue homeostasis. Moreover, lncRNAs are involved in pathological conditions such as cancer and cardiovascular disease, and therefore provide novel biomarkers and pharmaceutical targets. Here we discuss examples illustrating the versatility of lncRNAs in gene control, development and differentiation, as well as in human disease.

/pdf/mechanisms-of-long-noncoding-rna-function-in-development-and-51e1omeem4.pdf

Mechanisms of long noncoding RNA function in development and disease

Pseudogenes are thought to be inactive gene sequences, but recent evidence of extensive pseudogene transcription raised the question of potential function. Here we discover and characterize the sets of mouse lncRNAs induced by inflammatory signaling via TNFα. TNFα regulates hundreds of lncRNAs, including 54 pseudogene lncRNAs, several of which show exquisitely selective expression in response to specific cytokines and microbial components in a NF-κB-dependent manner. Lethe, a pseudogene lncRNA, is selectively induced by proinflammatory cytokines via NF-κB or glucocorticoid receptor agonist, and functions in negative feedback signaling to NF-κB. Lethe interacts with NF-κB subunit RelA to inhibit RelA DNA binding and target gene activation. Lethe level decreases with organismal age, a physiological state associated with increased NF-κB activity. These findings suggest that expression of pseudogenes lncRNAs are actively regulated and constitute functional regulators of inflammatory signaling.

DOI: http://dx.doi.org/10.7554/eLife.00762.001

/pdf/a-mammalian-pseudogene-lncrna-at-the-interface-of-2vr73n1xzd.pdf

A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics

Background Individuals with eating disorders (EDs) have increased rates of major depressive disorder (MDD) and anxiety disorders. Yet, few studies have investigated rates of EDs and their symptoms in individuals presenting with MDD/anxiety disorders. Identifying potential disordered eating in people with MDD/anxiety disorders is important because even subclinical disordered eating is associated with reduced quality of life, and undiagnosed eating pathology may hinder treatment progress for both MDD/anxiety disorders and comorbid EDs. Method We compared rates of EDs (anorexia nervosa, bulimia nervosa, binge-eating disorder, and other specified feeding and eating disorders) and their symptoms in 130 women with, and 405 women without, lifetime MDD or an anxiety disorder (generalized anxiety disorder, obsessive-compulsive disorder, social phobia, specific phobia, panic disorder, agoraphobia, or post-traumatic stress disorder) recruited from the population-based Michigan State University Twin Registry. Lifetime ED and MDD/anxiety diagnoses, and lifetime clinically significant disordered eating behaviors (e.g., binge eating, excessive exercise) were assessed using the Structured Clinical Interview for DSM-IV (SCID). Results Among participants with lifetime MDD or any anxiety disorder, 13% met criteria for a lifetime ED and 39% reported engaging in at least one lifetime clinically significant disordered eating behavior (e.g., binge eating) on the SCID. In contrast, only 3% of participants without a history of MDD/an anxiety disorder met criteria for a lifetime ED, and only 11% reported lifetime clinically significant disordered eating behavior. Discussion Our findings suggest that women with MDD and anxiety disorders have elevated rates of EDs, and it is therefore imperative to screen for disordered eating in these populations.

Increased rates of eating disorders and their symptoms in women with major depressive disorder and anxiety disorders

Ovarian hormones are associated with risk for binge eating in women. Recent animal and human studies suggest that food-related reward processing may be one set of neurobiological factors that contr...

/pdf/ovarian-hormones-and-reward-processes-in-palatable-food-3i7kqt8gce.pdf

Ovarian Hormones and Reward Processes in Palatable Food Intake and Binge Eating

While eating disorders affect people from all racial/ethnic backgrounds, research has traditionally focused on eating disorders in white populations. In this virtual issue, we present a collection of 14 articles previously published in the International Journal of Eating Disorders highlighting eating disorders in people of black/African and Indigenous heritage. Featured articles examine the prevalence and presentation of disordered eating in black and Indigenous populations; access to care and treatment experiences for black and Indigenous people; and environmental stressors, such as acculturative stress and discrimination, that may contribute to disordered eating in these populations. Future directions for inclusive research with people of black/African and Indigenous heritage are discussed, including reporting participant demographics, examining differences in risk factors and treatment outcomes across race/ethnicity, and partnering with black and Indigenous communities to produce culturally sensitive research attuned to the needs and priorities of these populations.

Megan E. Mikhail

Papers

A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics

Increased rates of eating disorders and their symptoms in women with major depressive disorder and anxiety disorders

Ovarian Hormones and Reward Processes in Palatable Food Intake and Binge Eating

A virtual issue highlighting eating disorders in people of black/African and Indigenous heritage.

Emotion regulation strategy use and eating disorder symptoms in daily life